News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
745,000 ^KRW	-1.32%		-5.70%	-1.97%

May. 23	US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz	MT
May. 06	Samsung Group Firms Set to Invest in US-based Latus Bio	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Samsung Biologics : Innovative solutions for bioprocessing challenges how MSAT drives efficient tech transfer	May. 26	PU
US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz	May. 23	MT
Samsung Group Firms Set to Invest in US-based Latus Bio	May. 06	MT
Samsung Biologics Reports First Quarter 2024 Financial Results	Apr. 25	AQ
Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	Apr. 25	MT
Samsung Biologics Posts Higher Q1 Profit, Sales	Apr. 25	MT
Samsung Biologics Boosts Contract Size with MSD Switzerland	Apr. 08	MT
Samsung Life Science Fund Invests in BrickBio	Mar. 20	AQ
Samsung Life Science Fund Invests in Biologics Developer	Mar. 20	MT
CEO IR Newsletter : 2024 AGM Wrap Up	Mar. 14	PU
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	Mar. 14	PU
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	Mar. 12	MT
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	Mar. 07	MT
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	Mar. 07	MT
Samsung Biologics signs MOU with Seoul National University to foster bio experts	Mar. 01	AQ
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	Feb. 29	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Samsung Biologics awarded Leadership status by CDP for climate action efforts	Feb. 14	AQ
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	Feb. 09	MT
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	Feb. 08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Summary

Filters